Cyclo(Phe-Pro) produced by the human pathogen Vibrio vulnificus inhibits host innate immune responses through the NF-κB pathway

Infect Immun. 2015 Mar;83(3):1150-61. doi: 10.1128/IAI.02878-14. Epub 2015 Jan 5.

Abstract

Cyclo(Phe-Pro) (cFP) is a secondary metabolite produced by certain bacteria and fungi. Although recent studies highlight the role of cFP in cell-to-cell communication by bacteria, its role in the context of the host immune response is poorly understood. In this study, we investigated the role of cFP produced by the human pathogen Vibrio vulnificus in the modulation of innate immune responses toward the pathogen. cFP suppressed the production of proinflammatory cytokines, nitric oxide, and reactive oxygen species in a lipopolysaccharide (LPS)-stimulated monocyte/macrophage cell line and in bone marrow-derived macrophages. Specifically, cFP inhibited inhibitory κB (IκB) kinase (IKK) phosphorylation, IκBα degradation, and nuclear factor κB (NF-κB) translocation to the cell nucleus, indicating that cFP affects the NF-κB pathway. We searched for genes that are responsible for cFP production in V. vulnificus and identified VVMO6_03017 as a causative gene. A deletion of VVMO6_03017 diminished cFP production and decreased virulence in subcutaneously inoculated mice. In summary, cFP produced by V. vulnificus actively suppresses the innate immune responses of the host, thereby facilitating its survival and propagation in the host environment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Cytokines / antagonists & inhibitors
  • Cytokines / biosynthesis
  • Dipeptides / biosynthesis
  • Dipeptides / pharmacology*
  • Gene Expression Regulation
  • Genes, Bacterial*
  • Host-Pathogen Interactions
  • Humans
  • I-kappa B Kinase / antagonists & inhibitors
  • I-kappa B Kinase / genetics
  • I-kappa B Kinase / immunology
  • Immunity, Innate
  • Lipopolysaccharides / pharmacology
  • Macrophages / cytology
  • Macrophages / drug effects
  • Macrophages / immunology
  • Mice
  • Mice, Inbred ICR
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / genetics
  • NF-kappa B / immunology
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide / biosynthesis
  • Peptides, Cyclic / biosynthesis
  • Peptides, Cyclic / pharmacology*
  • Phosphorylation
  • Protein Transport / drug effects
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism
  • Signal Transduction
  • Skin / immunology*
  • Skin / microbiology
  • Skin / pathology
  • Vibrio Infections / immunology*
  • Vibrio Infections / microbiology
  • Vibrio Infections / pathology
  • Vibrio vulnificus / genetics
  • Vibrio vulnificus / immunology*
  • Vibrio vulnificus / pathogenicity

Substances

  • Cytokines
  • Dipeptides
  • Lipopolysaccharides
  • NF-kappa B
  • Peptides, Cyclic
  • Reactive Oxygen Species
  • cyclo(phenylalanyl-prolyl)
  • Nitric Oxide
  • Chuk protein, mouse
  • I-kappa B Kinase